ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

HOWL Company Profile and Key Details

NASDAQ : HOWL

Werewolf Therapeutics, Inc.

$1.23

-0.01-0.81%

At Close 4:00 PM

61.96

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

HOWL Stock Price Chart

Stock Price Today

Werewolf Therapeutics, Inc. (HOWL) stock declined over -0.81%, trading at $1.23 on NASDAQ, down from the previous close of $1.24. The stock opened at $1.22, fluctuating between $1.20 and $1.29 in the recent session.

Stock Snapshot

1.24

Prev. Close

1.22

Open

54.81M

Market Cap

44.56M

Number of Shares

1.2

Day Low

1.29

Day High

-0.81

P/E Ratio

73.9%

Free Float in %

-1.52

EPS (TTM)

3.05

Book Value

-0.91

Cash Flow per Share

145.95K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Mar 07, 2025	1.22	1.29	1.20	1.23	146.27K
Mar 06, 2025	1.20	1.27	1.18	1.24	192.78K
Mar 05, 2025	1.17	1.29	1.17	1.24	263.5K
Mar 04, 2025	1.09	1.20	1.03	1.17	286.4K
Mar 03, 2025	1.25	1.28	1.13	1.14	242.3K
Feb 28, 2025	1.19	1.24	1.12	1.24	421.42K
Feb 27, 2025	1.28	1.30	1.16	1.16	479.62K
Feb 26, 2025	1.29	1.33	1.26	1.28	293.47K
Feb 25, 2025	1.35	1.36	1.27	1.28	355.75K
Feb 24, 2025	1.39	1.41	1.33	1.34	240.4K
Feb 21, 2025	1.41	1.44	1.37	1.38	221.31K
Feb 20, 2025	1.39	1.43	1.35	1.38	118K
Feb 19, 2025	1.45	1.46	1.40	1.40	139.26K
Feb 18, 2025	1.51	1.57	1.42	1.45	181.43K
Feb 14, 2025	1.52	1.54	1.44	1.49	197K
Feb 13, 2025	1.58	1.60	1.46	1.51	253.72K
Feb 12, 2025	1.52	1.55	1.45	1.52	207.75K
Feb 11, 2025	1.30	1.57	1.29	1.52	839.43K
Feb 10, 2025	1.35	1.36	1.28	1.33	405.15K
Feb 07, 2025	1.36	1.39	1.33	1.36	193.25K

Contact Details

Cambridge, MA 02138

United States

Website: https://werewolftx.comContact: 617 952 0555

About Company

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.

Frequently Asked Questions

What is the current Werewolf Therapeutics, Inc. (HOWL) stock price?

Werewolf Therapeutics, Inc. (NASDAQ: HOWL) stock price is $1.23 in the last trading session. During the trading session, HOWL stock reached the peak price of $1.29 while $1.20 was the lowest point it dropped to. The percentage change in HOWL stock occurred in the recent session was -0.81% while the dollar amount for the price change in HOWL stock was -$0.01.

HOWL's industry and sector of operation?

The NASDAQ listed HOWL is part of Biotechnology industry that operates in the broader Healthcare sector. Werewolf Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of HOWL?

Dr. Reid Leonard Ph.D.
Chief Operating Officer
Dr. Daniel J. Hicklin Ph.D.
Founder, Chief Executive Officer, Pres, Sec. & Director
Dr. Cynthia Seidel-Dugan Ph.D.
Chief Scientific Officer
Dr. Randi Isaacs M.D.
Chief Medical Officer
Mr. Timothy W. Trost CPA
Chief Financial Officer, Treasurer & Assistant Sec.
Dr. Chulani Karunatilake Ph.D.
Chief Technology Officer
Ms. Ellen A. Lubman M.B.A.
Chief Bus. Officer

How HOWL did perform over past 52-week?

HOWL's closing price is 19.42% higher than its 52-week low of $1.03 where as its distance from 52-week high of $6.89 is -82.63%.

How many employees does HOWL have?

Number of HOWL employees currently stands at 45.

Link for HOWL official website?

Official Website of HOWL is: https://werewolftx.com

How do I contact HOWL?

HOWL could be contacted at phone 617 952 0555 and can also be accessed through its website. HOWL operates from 1030 Massachusetts Avenue, Cambridge, MA 02138, United States.

How many shares of HOWL are traded daily?

HOWL stock volume for the day was 145.95K shares. The average number of HOWL shares traded daily for last 3 months was 292.57K.

What is the market cap of HOWL currently?

The market value of HOWL currently stands at $54.81M with its latest stock price at $1.23 and 44.56M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Employees	45
Beta	0.38
Sales or Revenue	$19.94M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology